Dr. Howard Bruckner, Chief Science Officer of the MZB Foundation for Cancer Research Publishes in PLOS ONE

A group of 205 patients expected to live less than 10 months have 2-3x greater survival with new treatments. Blood tests predict survival.

NEW YORK , NY, UNITES STATES, November 2, 2022 /⁨EINPresswire.com⁩/ — ‘Actionable Tests and Treatments …